[Translation] A single-center, double-blind, randomized, placebo-controlled, repeated-dose escalation study to evaluate the pharmacokinetics, safety, and tolerability of inhaled CHF6001 in healthy Chinese subjects
表征中国健康受试者重复给药CHF6001 DPI后CHF6001的药代动力学(PK)特征。
[Translation] To characterize the pharmacokinetic (PK) profile of CHF6001 after repeated administration of CHF6001 DPI in healthy Chinese subjects.